Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cs-758
2. R-120758
1. Embeconazole [inn]
2. Cs-758
3. 329744-44-7
4. R-120758
5. 02b953tlai
6. 4-[(1e,3e)-4-[5-[(2r,3r)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]sulfanyl-1,3-dioxan-2-yl]buta-1,3-dienyl]-3-fluorobenzonitrile
7. Unii-02b953tlai
8. 4-((1e,3e)-4-(trans-5-(((1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl)thio)-1,3-dioxan-2-yl)-1,3-butadienyl)-3-fluorobenzonitrile
9. 4-[(1e,3e)-4-[trans-5-[[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-yl]-1,3-butadienyl]-3-fluorobenzonitrile
10. Chembl475786
11. Schembl2927801
12. Schembl2927804
13. Schembl2927807
14. Schembl4681178
15. Cs-758, R-120758
16. Q27231514
17. (2r,3r)-1-(1h-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-[2alpha-[(1e,3e)-4-(2-fluoro-4-cyanophenyl)-1,3-butadienyl]-1,3-dioxane-5beta-ylthio]-2-butanol
18. (2r,3r)-3-[[trans-2-[(1e,3e)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1-h-1,2,4-triazol-1-yl)-2-butanol
19. (2r,3r)-3-[[trans-2-[(1e,3e)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol
20. 4-((1e,3e)-4-(trans-5-(((2r,3r)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1h-1,2,4-triazol-1-yl)butan-2-yl)sulfanyl)-1,3-dioxan-2-yl)buta-1,3-dien-1-yl)-3-fluorobenzonitrile
21. 4-[(1e,3e)-4-[5-[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1,2,4-triazol-1-yl)propyl]sulfanyl-1,3-dioxan-2-yl]buta-1,3-dienyl]-3-fluoro-benzonitrile
22. Benzonitrile, 4-[(1e,3e)-4-[5-[[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-yl]-1,3-butadienyl]-3-fluoro-
Molecular Weight | 542.6 g/mol |
---|---|
Molecular Formula | C27H25F3N4O3S |
XLogP3 | 4.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 542.15994633 g/mol |
Monoisotopic Mass | 542.15994633 g/mol |
Topological Polar Surface Area | 119 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 868 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 2 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
31
PharmaCompass offers a list of Embeconazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Embeconazole manufacturer or Embeconazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Embeconazole manufacturer or Embeconazole supplier.
PharmaCompass also assists you with knowing the Embeconazole API Price utilized in the formulation of products. Embeconazole API Price is not always fixed or binding as the Embeconazole Price is obtained through a variety of data sources. The Embeconazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Embeconazole manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Embeconazole, including repackagers and relabelers. The FDA regulates Embeconazole manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Embeconazole API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Embeconazole supplier is an individual or a company that provides Embeconazole active pharmaceutical ingredient (API) or Embeconazole finished formulations upon request. The Embeconazole suppliers may include Embeconazole API manufacturers, exporters, distributors and traders.
Embeconazole Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Embeconazole GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Embeconazole GMP manufacturer or Embeconazole GMP API supplier for your needs.
A Embeconazole CoA (Certificate of Analysis) is a formal document that attests to Embeconazole's compliance with Embeconazole specifications and serves as a tool for batch-level quality control.
Embeconazole CoA mostly includes findings from lab analyses of a specific batch. For each Embeconazole CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Embeconazole may be tested according to a variety of international standards, such as European Pharmacopoeia (Embeconazole EP), Embeconazole JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Embeconazole USP).